Loading clinical trials...
Loading clinical trials...
The Efficacy and Safety of Qishenyiqi Dripping Pill in Patients With Coronary Microvascular Disease
Conditions
Interventions
Qishenyiqi dripping pills 1 bag, three times a day
Placebo 1 bag, three times a day
Locations
3
China
Qianfoshan Hospital, Shandong University
Jinan, Shandong, China
Qilu Hospital of Shandong University
Jinan, Shandong, China
Jinan Central Hospital Affiliated to Shandong First Medical University
Jinan, Shandong, China
Start Date
November 8, 2023
Primary Completion Date
December 31, 2025
Completion Date
June 30, 2026
Last Updated
November 21, 2024
NCT06991322
NCT05743140
NCT06125392
NCT06597851
NCT05178914
NCT05913999
Lead Sponsor
Qilu Hospital of Shandong University
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions